Locations:
Min Investment:
Max Investment:
Target Investment:
FRCS(Plast)
(2004 - 2013)
(1992 - 1997)
(1983 - 1992)
2018
2016 - 2018
2017 - 2018
Commercial lead for assets up to candidate selection, FTH and up to Ph2b and a commit to medicines development milestone in the Immuno-Inflammation Therapy Area Unit
2016 - 2017
Late phase clinical development Ph3 registrational trial NDA and global medical affairs for a rheumatoid arthritis asset in the Immuno-Inflammation Therapy Area Unit
2015 - 2016
2015 - 2016
2015 - 2015
2015 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2014 - 2015
2007 - 2014
2007 - 2014